Peripheral Artery Disease (PAD)


In this article, three unique clinical scenarios are presented in which endovascular therapy prevented major amputations and improved patient outcomes.
Dr. Gary Ansel explains the importance of choosing the right treatment algorithm for SFA disease in the COVID-19 environment and provides an overview of the complimentary one-hour CME-accredited course.
Paul Michael, MD, and Richard Neville, MD, discuss how to work across disciplines to help improve outcomes for patients with CLI.
Presented at ISET 2020 by Bret N. Wiechmann, MD, FSIR, FAHA, FSVM.
Presented at ISET 2020 by Fadi A. Saab, MD, FACC, FSCAI, FASE. TAMI stands for Tibiopedal Arterial Minimally Invasive retrograde revascularization.
Hear from George L. Adams, MD, MHS, MBA, FACC, FSCAI, in his presentation at the International Symposium on Endovascular Therapy (ISET) 2020 meeting.
Featuring Mehdi H. Shishehbor, DO, PhD, MPH, Director, Interventional Cardiovascular Center, Co-Director, Vascular Center, Harrington Heart and Vascular Institute, University Hospitals, Cleveland, Ohio.
We suggest approaching the important topic of alternative arterial access with the following questions: 1) WHAT is it?; 2) WHY is it needed?; 3) WHERE are the access sites?; 4) HOW safe is it?
We present a case demonstrating use of directional atherectomy technology below the ankle for revascularization of the pedal loop to demonstrate that atherectomy + PTA may be more beneficial to PTA alone in maximizing patient outcomes.